ADIAL PHARMACEUTICALS, INC. research brief

CIK 1513525 Copy CIK

Generated Nov. 14, 2026, 12:28 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: GLEN ALLEN Virginia. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Dec. 3, 2025 · D · 0001213900-25-117804 · Source evidence

  Reported offering amount: 4285289 USD. Reported amount sold: 4285289 USD.

• May 14, 2025 · D · 0001213900-25-042848 · Source evidence

  Reported offering amount: 4815379 USD. Reported amount sold: 4815379 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “ADIAL PHARMACEUTICALS, INC. research brief,” CIK 1513525, retrieved Nov. 14, 2026, 12:28 a.m.. Cite the specific accessions used. No amounts have been summed.